The minimum basophil percentage resulted predictive up to 1 year prior the BCR-ABL1 test and it was the only variable considered in the model of prediction at 1 year and 6 months before the CML diagnostic test. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.